ACADIA Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACAD Nasdaq 2836 www.acadia.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome - Dec 12th, 2025 6:00 am
Rhythm Pharma Hits Record High On Unexpected Obesity-Tied Win - Dec 11th, 2025 2:27 pm
Why Is CRISPR Therapeutics (CRSP) Up 3.3% Since Last Earnings Report? - Dec 10th, 2025 9:30 am
Assessing ACADIA Pharmaceuticals Valuation After Strong 2024 Share Price Rally - Dec 6th, 2025 1:09 pm
ACADIA Pharmaceuticals (ACAD) Is Up 9.6% After Earnings Beat And NUPLAZID Patent Extension News - Dec 6th, 2025 10:09 am
Assessing Acadia Pharmaceuticals (ACAD) Valuation After Strong Q3 Results and Extended NUPLAZID Patent Protection - Dec 6th, 2025 8:11 am
Why Is Acadia (ACAD) Up 22.6% Since Last Earnings Report? - Dec 5th, 2025 9:30 am
Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? - Dec 3rd, 2025 5:32 pm
Acadia to pivot to Alzheimer’s psychosis pipeline, accd to Wall Street analysts - Dec 3rd, 2025 7:17 am
Acadia Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference - Nov 20th, 2025 2:05 pm
Statutory Earnings May Not Be The Best Way To Understand ACADIA Pharmaceuticals' (NASDAQ:ACAD) True Position - Nov 13th, 2025 3:24 am
Is ACADIA’s Raised Guidance and Acquisition Plans Reshaping the Investment Narrative for ACAD? - Nov 9th, 2025 3:08 am
Intellia Q3 Loss Narrower Than Expected, Stock Down on Pipeline Trouble - Nov 7th, 2025 7:56 am
ACAD Q3 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth - Nov 6th, 2025 9:23 am
Catalyst Pharmaceuticals Q3 Earnings Beat, Firdapse Revenues Rise Y/Y - Nov 6th, 2025 8:43 am
RXRX Q3 Loss Narrower Than Expected, Revenues Decline Y/Y - Nov 6th, 2025 7:24 am
ACADIA Pharmaceuticals Inc (ACAD) Q3 2025 Earnings Call Highlights: Record Sales and Strategic ... - Nov 5th, 2025 10:00 pm
Acadia (ACAD) Q3 2025 Earnings Call Transcript - Nov 5th, 2025 5:12 pm
Acadia Pharmaceuticals (ACAD) Q3 Earnings and Revenues Top Estimates - Nov 5th, 2025 3:20 pm
Acadia: Q3 Earnings Snapshot - Nov 5th, 2025 2:18 pm